UTRECHT, Netherlands, April 5, 2014 /PRNewswire/ -- Elekta (NSE:EKTAb), Royal Philips (NYSE:PHG, AEX:PHIA) and University Medical Center (UMC) Utrecht ( the Netherlands) announced today that the initial components of the world's first high-field magnetic resonance imaging (MRI) guided radiation therapy system are being installed at UMC Utrecht. This marks a significant milestone toward the development of a clinical system capable of capturing highly detailed MR images of tumors and surrounding normal tissues as a patient receives radiotherapy. Development of the high-field MRI-guided linear accelerator (linac) is the mission of the MR Linac Research Consortium headed by Elekta and supported by Philips.
The integration of an advanced Philips 1.5 Tesla MRI system with a sophisticated Elekta radiation therapy system – enabling simultaneous imaging during beam delivery – could allow doctors to adapt radiation therapy during the procedure, increasing treatment accuracy, potentially reducing side effects and enabling increases in the therapeutic dose.
On April 5, the first component – the system's ring gantry on which linac parts are mounted – was lowered by crane through a modular roof into one of UMC Utrecht's radiotherapy treatment rooms. In the coming months, additional components will be integrated and the system will undergo a program of non-clinical testing, which includes the performance evaluation of MRI sequences, testing of different adaptive delivery methods, establishing quality assurance techniques and defining workflow.
"Since formation of the consortium in 2012, members have been exploring the feasibility of high-field MRI-guided radiotherapy. Installation of the first generation system is truly a major step toward moving this technology into the clinic to benefit patients," says Bas Raaymakers, PhD, Associate Professor, Department of Radiotherapy, UMC Utrecht. "We're immensely proud of the critical role that UMC Utrecht has played in collaboration with Philips and Elekta in this project for over 10 years.""As the founding member of the consortium, UMC Utrecht has been instrumental in turning the concept of MRI guided radiation therapy into a working system, and has invested a great deal of effort and resources to make it a reality," adds Tomas Puusepp, President and CEO, Elekta. "We are excited about the prospect of taking high-field MRI-guided radiation therapy to the next stage." "Highly targeted treatments will be essential in the battle to control cancer, so together with our partners we are stepping up our efforts to create new solutions in interventional oncology," says Gene Saragnese, CEO Imaging Systems at Philips Healthcare. "The installation of the first generation MR-guided radiation system at UMC Utrecht is an important milestone in the development of an innovation that is designed to make a real difference in cancer care." In addition to UMC Utrecht, the other consortium members are: The University of Texas MD Anderson Cancer Center ( Houston, Texas), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital ( Amsterdam, the Netherlands), Sunnybrook Health Sciences Centre ( Toronto, Ontario) and The Froedtert & Medical College of Wisconsin Cancer Center ( Milwaukee, Wisconsin). For further information, please contact: Gert van Santen, Group Vice President Corporate Communications, Elekta ABTel: +31 653 561 242, e-mail: email@example.comTime zone: CET: Central European Time Michelle Joiner, Director, Global Public Relations and Brand Management, ElektaTel: +1 770-670-2447, e-mail: firstname.lastname@example.orgTime zone: EST: Eastern Standard Time Steve Klink, Philips Group CommunicationsTel: +31 6 10888824, e-mail: email@example.com Paul Geurts, Coordinator Media Relations, UMC UtrechtTel: +31 88 7 555 000, e-mail: firstname.lastname@example.org About ElektaElekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com. About Royal Philips: Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter. About University Medical Center UtrechtUniversity Medical Center Utrecht (UMC Utrecht) belongs to the largest public healthcare institutions in the Netherlands. UMC Utrecht has the ambition to be a leading international healthcare provider, medical school and research institute. UMC Utrecht employs 11,000 people that are dedicated to prevent disease, improve healthcare, develop new treatment methods and refine existing ones, with patient safety and quality as cornerstones. For more information, visit www.umcutrecht.nl. SOURCE Elekta
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts